Focal tectal tumors

Management and prognosis

Liza A. Squires, Jeffrey C. Allen, Ira Richmond Abbott, III, Fred J. Epstein

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

A 7-year review at our institution identified 12 children with midbrain tectal tumors. All presented with signs of increased intracranial pressure, had hydrocephalus on initial imaging, and were treated with ventriculoperitoneal (VP) shunts. Three had clinical and radiographic progression of disease. Two were treated with radiation and chemotherapy, with progression of disease in one. The third received radiation alone. All patients are alive, with a median follow-up of over 4 years. Median progression-free survival is at least 24 months and median total survival is beyond 50 months. The tectal glioma syndrome is a relatively benign variant of the brainstem glioma. The majority of patients may be managed with a VP shunt alone.

Original languageEnglish (US)
Pages (from-to)953-956
Number of pages4
JournalNeurology
Volume44
Issue number5
StatePublished - May 1994
Externally publishedYes

Fingerprint

Ventriculoperitoneal Shunt
Glioma
Disease Progression
Brain Stem Neoplasms
Radiation
Intracranial Pressure
Hydrocephalus
Brain Stem
Disease-Free Survival
Neoplasms
Drug Therapy
Survival

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Squires, L. A., Allen, J. C., Abbott, III, I. R., & Epstein, F. J. (1994). Focal tectal tumors: Management and prognosis. Neurology, 44(5), 953-956.

Focal tectal tumors : Management and prognosis. / Squires, Liza A.; Allen, Jeffrey C.; Abbott, III, Ira Richmond; Epstein, Fred J.

In: Neurology, Vol. 44, No. 5, 05.1994, p. 953-956.

Research output: Contribution to journalArticle

Squires, LA, Allen, JC, Abbott, III, IR & Epstein, FJ 1994, 'Focal tectal tumors: Management and prognosis', Neurology, vol. 44, no. 5, pp. 953-956.
Squires LA, Allen JC, Abbott, III IR, Epstein FJ. Focal tectal tumors: Management and prognosis. Neurology. 1994 May;44(5):953-956.
Squires, Liza A. ; Allen, Jeffrey C. ; Abbott, III, Ira Richmond ; Epstein, Fred J. / Focal tectal tumors : Management and prognosis. In: Neurology. 1994 ; Vol. 44, No. 5. pp. 953-956.
@article{9105d1af3f0a4fd29b82e8800d47d762,
title = "Focal tectal tumors: Management and prognosis",
abstract = "A 7-year review at our institution identified 12 children with midbrain tectal tumors. All presented with signs of increased intracranial pressure, had hydrocephalus on initial imaging, and were treated with ventriculoperitoneal (VP) shunts. Three had clinical and radiographic progression of disease. Two were treated with radiation and chemotherapy, with progression of disease in one. The third received radiation alone. All patients are alive, with a median follow-up of over 4 years. Median progression-free survival is at least 24 months and median total survival is beyond 50 months. The tectal glioma syndrome is a relatively benign variant of the brainstem glioma. The majority of patients may be managed with a VP shunt alone.",
author = "Squires, {Liza A.} and Allen, {Jeffrey C.} and {Abbott, III}, {Ira Richmond} and Epstein, {Fred J.}",
year = "1994",
month = "5",
language = "English (US)",
volume = "44",
pages = "953--956",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Focal tectal tumors

T2 - Management and prognosis

AU - Squires, Liza A.

AU - Allen, Jeffrey C.

AU - Abbott, III, Ira Richmond

AU - Epstein, Fred J.

PY - 1994/5

Y1 - 1994/5

N2 - A 7-year review at our institution identified 12 children with midbrain tectal tumors. All presented with signs of increased intracranial pressure, had hydrocephalus on initial imaging, and were treated with ventriculoperitoneal (VP) shunts. Three had clinical and radiographic progression of disease. Two were treated with radiation and chemotherapy, with progression of disease in one. The third received radiation alone. All patients are alive, with a median follow-up of over 4 years. Median progression-free survival is at least 24 months and median total survival is beyond 50 months. The tectal glioma syndrome is a relatively benign variant of the brainstem glioma. The majority of patients may be managed with a VP shunt alone.

AB - A 7-year review at our institution identified 12 children with midbrain tectal tumors. All presented with signs of increased intracranial pressure, had hydrocephalus on initial imaging, and were treated with ventriculoperitoneal (VP) shunts. Three had clinical and radiographic progression of disease. Two were treated with radiation and chemotherapy, with progression of disease in one. The third received radiation alone. All patients are alive, with a median follow-up of over 4 years. Median progression-free survival is at least 24 months and median total survival is beyond 50 months. The tectal glioma syndrome is a relatively benign variant of the brainstem glioma. The majority of patients may be managed with a VP shunt alone.

UR - http://www.scopus.com/inward/record.url?scp=0028278502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028278502&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 953

EP - 956

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 5

ER -